Downregulated Expression of Peroxiredoxin 4 in Granulosa Cells from Polycystic Ovary Syndrome

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Meng, Yan ^a   Qian, Yi ^a   Gao, Li ^a   Cai, Ling Bo ^a   Cui, Yu Gui ^a   Liu, Jia Yin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEROXIREDOXIN 4;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION;

ADULT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; GRANULOSA CELLS; HUMANS; MODELS, BIOLOGICAL; OVARIAN FOLLICLE; OVARY; PEROXIREDOXINS; POLYCYSTIC OVARY SYNDROME; RNA, MESSENGER; YOUNG ADULT;

EID: 84884895232     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076460     Document Type: Article

References (43)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, et al. (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745-2749.
2. Franks S, (1989) Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf) 31: 87-120.
3. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, et al. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10: 2107-2111.
4. Hughesdon PE, (1982) Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". Obstet Gynecol Surv 37: 59-77.
5. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, et al. (2003) Formation and early development of follicles in the polycystic ovary. Lancet 362: 1017-1021.
6. Franks S, Stark J, Hardy K, (2008) Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14: 367-378.
7. Karuputhula NB, Chattopadhyay R, Chakravarty B, Chaudhury K, (2013) Oxidative status in granulosa cells of infertile women undergoing IVF. Syst Biol Reprod Med 59: 91-98.
8. Devine PJ, Perreault SD, Luderer U, (2012) Roles of reactive oxygen species and antioxidants in ovarian toxicity. Biol Reprod 86: 27.
9. Al-Gubory KH, Fowler PA, Garrel C, (2010) The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 42: 1634-1650.
10. Nakahara K, Saito H, Saito T, Ito M, Ohta N, et al. (1997) The incidence of apoptotic bodies in membrana granulosa can predict prognosis of ova from patients participating in in vitro fertilization programs. Fertil Steril 68: 312-317.
11. Oosterhuis GJ, Michgelsen HW, Lambalk CB, Schoemaker J, Vermes I, (1998) Apoptotic cell death in human granulosa-lutein cells: a possible indicator of in vitro fertilization outcome. Fertil Steril 70: 747-749.
12. Rhee SG, Chae HZ, Kim K, (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552.
13. Rhee SG, Woo HA, Kil IS, Bae SH, (2012) Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem 287: 4403-4410.
14. Lee HC, Lee SW, Lee KW, Cha KY, Kim KH, et al. (2005) Identification of new proteins in follicular fluid from mature human follicles by direct sample rehydration method of two-dimensional polyacrylamide gel electrophoresis. J Korean Med Sci 20: 456-460.
15. Leyens G, Verhaeghe B, Landtmeters M, Marchandise J, Knoops B, et al. (2004) Peroxiredoxin 6 is upregulated in bovine oocytes and cumulus cells during in vitro maturation: role of intercellular communication. Biol Reprod 71: 1646-1651.
16. Kang SW, Rhee SG, Chang TS, Jeong W, Choi MH, (2005) 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol Med 11: 571-578.
17. Meng Y, Liu XH, Ma X, Shen Y, Fan L, et al. (2007) The protein profile of mouse mature cumulus-oocyte complex. Biochim Biophys Acta 1774: 1477-1490.
18. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47.
19. Vermeulen A, Verdonck L, Kaufman JM, (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666-3672.
20. Catteau-Jonard S, Jamin SP, Leclerc A, Gonzales J, Dewailly D, et al. (2008) Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93: 4456-4461.
21. Chian RC, Gulekli B, Buckett WM, Tan SL (1999) Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med 341: 1624, 1626.
22. Xie D, Zeng YX, Wang HJ, Wen JM, Tao Y, et al. (2006) Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br J Cancer 94: 108-114.
23. Ding Y, Yamada S, Wang KY, Shimajiri S, Guo X, et al. (2010) Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice. Antioxid Redox Signal 13: 1477-1490.
24. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
25. Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, et al. (2005) Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 115: 2192-2201.
26. Jin DY, Chae HZ, Rhee SG, Jeang KT, (1997) Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem 272: 30952-30961.
27. Tavender TJ, Bulleid NJ, (2010) Peroxiredoxin IV protects cells from oxidative stress by removing H2O2 produced during disulphide formation. J Cell Sci 123: 2672-2679.
28. Iuchi Y, Okada F, Tsunoda S, Kibe N, Shirasawa N, et al. (2009) Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress. Biochem J 419: 149-158.
29. Tavender TJ, Sheppard AM, Bulleid NJ, (2008) Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochem J 411: 191-199.
30. Palande KK, Beekman R, van der Meeren LE, Beverloo HB, Valk PJ, et al. (2011) The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia. PLoS One 6: e16340.
31. Wei Q, Jiang H, Xiao Z, Baker A, Young MR, et al. (2011) Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. Proc Natl Acad Sci U S A 108: 7004-7009.
32. Erickson GF, Magoffin DA, Garzo VG, Cheung AP, Chang RJ, (1992) Granulosa cells of polycystic ovaries: are they normal or abnormal? Hum Reprod 7: 293-299.
33. Burton GJ, Jauniaux E, (2011) Oxidative stress. Best Pract Res Clin Obstet Gynaecol 25: 287-299.
34. Cindrova-Davies T, Yung HW, Johns J, Spasic-Boskovic O, Korolchuk S, et al. (2007) Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol 171: 1168-1179.
35. Victor VM, Rocha M, Banuls C, Alvarez A, de Pablo C, et al. (2011) Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab 96: 3115-3122.
36. Murri M, Luque-Ramirez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update.
37. Palacio JR, Iborra A, Ulcova-Gallova Z, Badia R, Martinez P, (2006) The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin Exp Immunol 144: 217-222.
38. Haridas V, Ni J, Meager A, Su J, Yu GL, et al. (1998) TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase. J Immunol 161: 1-6.
39. Gonzalez F, Rote NS, Minium J, Kirwan JP, (2006) Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 91: 1508-1512.
40. Peter AT, Dhanasekaran N, (2003) Apoptosis of granulosa cells: a review on the role of MAPK-signalling modules. Reprod Domest Anim 38: 209-213.
41. Suzuki T, Sugino N, Fukaya T, Sugiyama S, Uda T, et al. (1999) Superoxide dismutase in normal cycling human ovaries: immunohistochemical localization and characterization. Fertil Steril 72: 720-726.
42. Agarwal A, Gupta S, Sharma RK, (2005) Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3: 28.
43. Hennet ML, Yu HY, Combelles CM, (2013) Follicular fluid hydrogen peroxide and lipid hydroperoxide in bovine antral follicles of various size, atresia, and dominance status. J Assist Reprod Genet 30: 333-340.